Literature DB >> 20720104

Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome.

Lulu Y Chen1, Christopher S Rex, Alex H Babayan, Eniko A Kramár, Gary Lynch, Christine M Gall, Julie C Lauterborn.   

Abstract

The abnormal spine morphology found in fragile X syndrome (FXS) is suggestive of an error in the signaling cascades that organize the actin cytoskeleton. We report here that physiological activation of the small GTPase Rac1 and its effector p-21 activated kinase (PAK), two enzymes critically involved in actin management and functional synaptic plasticity, is impaired at hippocampal synapses in the Fmr1-knock-out (KO) mouse model of FXS. Theta burst afferent stimulation (TBS) caused a marked increase in the number of synapses associated with phosphorylated PAK in adult hippocampal slices from wild-type, but not Fmr1-KO, mice. Stimulation-induced activation of synaptic Rac1 was also absent in the mutants. The polymerization of spine actin that occurs immediately after theta stimulation appeared normal in mutant slices but the newly formed polymers did not properly stabilize, as evidenced by a prolonged vulnerability to a toxin (latrunculin) that disrupts dynamic actin filaments. Latrunculin also reversed long-term potentiation when applied at 10 min post-TBS, a time point at which the potentiation effect is resistant to interference in wild-type slices. We propose that a Rac>PAK signaling pathway needed for rapid stabilization of activity-induced actin filaments, and thus for normal spine morphology and lasting synaptic changes, is defective in FXS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720104      PMCID: PMC2929244          DOI: 10.1523/JNEUROSCI.1077-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity.

Authors:  C Chong; L Tan; L Lim; E Manser
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

2.  Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus.

Authors:  T Krucker; G R Siggins; S Halpain
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

4.  Glutamate receptor targeting in the postsynaptic spine involves mechanisms that are independent of myosin Va.

Authors:  R S Petralia; Y X Wang; N Sans; P F Worley; J A Hammer ; R J Wenthold
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

Review 5.  Dendritic spine pathology: cause or consequence of neurological disorders?

Authors:  John C Fiala; Josef Spacek; Kristen M Harris
Journal:  Brain Res Brain Res Rev       Date:  2002-06

6.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

Authors:  S A Irwin; B Patel; M Idupulapati; J B Harris; R A Crisostomo; B P Larsen; F Kooy; P J Willems; P Cras; P B Kozlowski; R A Swain; I J Weiler; W T Greenough
Journal:  Am J Med Genet       Date:  2001-01-15

7.  Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor.

Authors:  Sachiyo Ohashi; Katsuya Koike; Akira Omori; Sachiyo Ichinose; Susumu Ohara; Shunsuke Kobayashi; Taka-Aki Sato; Kaijiro Anzai
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

Review 8.  Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes.

Authors:  Barbara Bardoni; Jean-Louis Mandel
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

Review 9.  Integration of signals to the Arp2/3 complex.

Authors:  Alissa M Weaver; Michael E Young; Wei-Lih Lee; John A Cooper
Journal:  Curr Opin Cell Biol       Date:  2003-02       Impact factor: 8.382

10.  Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice.

Authors:  Scott A Irwin; Madhuri Idupulapati; Molly E Gilbert; Jennifer B Harris; Aparna B Chakravarti; Erica J Rogers; Ralph A Crisostomo; Brian P Larsen; Amit Mehta; C J Alcantara; Biraju Patel; Rodney A Swain; Ivan Jeanne Weiler; Ben A Oostra; William T Greenough
Journal:  Am J Med Genet       Date:  2002-08-01
View more
  72 in total

Review 1.  Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines.

Authors:  Peter Penzes; Michael E Cahill
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-12

2.  Rho GTPase RAC1 at the Molecular Interface Between Genetic and Environmental Factors of Autism Spectrum Disorders.

Authors:  Fares Zeidán-Chuliá; Alla B Salmina; Mami Noda; Alexei Verkhratsky
Journal:  Neuromolecular Med       Date:  2015-08-25       Impact factor: 3.843

Review 3.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

4.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

5.  GluN3A expression restricts spine maturation via inhibition of GIT1/Rac1 signaling.

Authors:  Maria Fiuza; Immaculada González-González; Isabel Pérez-Otaño
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

6.  Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.

Authors:  Jonathan W Lovelace; Maham Rais; Arnold R Palacios; Xinghao S Shuai; Steven Bishay; Otilia Popa; Patricia S Pirbhoy; Devin K Binder; David L Nelson; Iryna M Ethell; Khaleel A Razak
Journal:  Cereb Cortex       Date:  2020-03-14       Impact factor: 5.357

Review 7.  Mechanisms for spatiotemporal regulation of Rho-GTPase signaling at synapses.

Authors:  Joseph G Duman; Shalaka Mulherkar; Yen-Kuei Tu; Jinxuan X Cheng; Kimberley F Tolias
Journal:  Neurosci Lett       Date:  2015-05-21       Impact factor: 3.046

Review 8.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

9.  Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome.

Authors:  Julie C Lauterborn; Matiar Jafari; Alex H Babayan; Christine M Gall
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

10.  Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.

Authors:  Bianca De Filippis; Paola Nativio; Alessia Fabbri; Laura Ricceri; Walter Adriani; Enza Lacivita; Marcello Leopoldo; Francesca Passarelli; Andrea Fuso; Giovanni Laviola
Journal:  Neuropsychopharmacology       Date:  2014-05-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.